1GA
ELV icon

1st Global Advisors’s Elevance Health ELV Stock Holding History

1st Global Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$367K Sell
1,949
-13
-0.7% -$2.34K 0.04% 332
2017
Q1 		$324K Sell
1,962
-295
-13% -$46.9K 0.04% 358
2016
Q4 		$324K Sell
2,257
-22
-1% -$2.95K 0.04% 357
2016
Q3 		$286K Sell
2,279
-656
-22% -$84.7K 0.04% 386
2016
Q2 		$385K Sell
2,935
-1,525
-34% -$209K 0.05% 294
2016
Q1 		$620K Sell
4,460
-6,131
-58% -$819K 0.09% 202
2015
Q4 		$1.48M Buy
10,591
+244
+2% +$33.6K 0.22% 55
2015
Q3 		$1.45M Buy
10,347
+97
+0.9% +$14.6K 0.23% 51
2015
Q2 		$1.68K Buy
10,250
+493
+5% +$78.8K 0.25% 51
2015
Q1 		$1.51M Sell
9,757
-242
-2% -$34.5K 0.22% 63
2014
Q4 		$1.26M Buy
9,999
+407
+4% +$50.3K 0.18% 64
2014
Q3 		$1.15M Buy
+9,592
New +$1.1M 0.18% 70

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

1st Global Advisors's ELV Position: Q2 2017 in Review

1st Global Advisors reduced its Elevance Health (ELV) stake by 0.66% in Q2 2017, selling an estimated $2.34K and leaving 1,949 shares worth $367K. The position accounts for 0.04% of the portfolio, ranked #332.

1st Global Advisors first reported a position in ELV in Q3 2014 and has held it in 12 quarters since. The position peaked at $1.51M in Q1 2015. 851 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • 1st Global Advisors held 1,949 shares of Elevance Health worth $367K as of Q2 2017.
  • 1st Global Advisors sold 13 Elevance Health shares in Q2 2017, an estimated $2.34K.
  • Elevance Health made up 0.04% of 1st Global Advisors's portfolio in Q2 2017, its #332 holding.
  • 1st Global Advisors first reported a position in Elevance Health in Q3 2014 and has held it in 12 quarters since.
  • 1st Global Advisors's Elevance Health position peaked at $1.51M in Q1 2015.
  • 851 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on 1st Global Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.